Form 4: MindMed Director Suzanne Bruhn Granted 75,187 Stock Options

Mind Medicine (MindMed) Inc. director Suzanne Louise Bruhn was granted 75,187 stock options with an exercise price of $7.3, as disclosed in a recent SEC Form 4 filing.

Summary

• Suzanne Louise Bruhn, a Director of Mind Medicine (MindMed) Inc. (MNMD), was granted 75,187 stock options.
• The transaction date for this acquisition was June 12, 2025.
• Each stock option has an exercise price of $7.3.
• The options are exercisable into 75,187 common shares of Mind Medicine (MindMed) Inc.
• The expiration date for these stock options is June 11, 2035.
• The stock options vest and become exercisable as to 1/12th of the underlying shares on each monthly anniversary of the grant date.
• An accelerated vesting condition states that if the Company's annual meeting immediately following the grant date occurs prior to the first anniversary, the options will vest immediately prior to that annual meeting.
• Vesting is contingent upon the Reporting Person's continued service through the applicable vesting date.

Sentiment

Score: 7

Explanation: The document reports a routine insider transaction related to director compensation. It is a neutral event with a slight positive tilt due to the alignment of director interests with shareholder value.

Positives

• The grant of stock options aligns the director's financial interests with the long-term performance and shareholder value creation of Mind Medicine (MindMed) Inc.

Future Outlook

The document details the vesting schedule for the granted stock options, indicating future dates when the options will become exercisable, contingent on continued service. It does not provide a broader future outlook for the company's financial performance or strategic direction.

Industry Context

The grant of stock options to a director is a standard practice in the corporate world, commonly used as a form of equity compensation to incentivize and align the interests of key personnel with the company's long-term success and shareholder value.

Stakeholder Impact

• Shareholders: The grant of stock options to a director is intended to align the director's incentives with the long-term interests of shareholders, potentially leading to improved company performance and shareholder value.

Next Steps

• The stock options will vest monthly over a period, or potentially accelerate vesting prior to the company's annual meeting, subject to the director's continued service.

Key Dates

Keywords

Mind Medicine, MNMD, Stock Option, Equity Grant, Director Compensation, Insider Transaction, SEC Form 4, Beneficial Ownership